Arrowhead Pharmaceuticals, Inc. today announced that the Australian Therapeutic Goods Administration (TGA) has approved REDEMPLO® (plozasiran), a small interfering RNA (siRNA) medicine, as an adjunct ...
Keenova Therapeutics plc announced today that a new presentation on hepatorenal syndrome-acute kidney injury (HRS?AKI) and TERLIVAZ® (terlipressin) will be shared at Digestive Disease Week (DDW), ...
Entropy Neurodynamics and LTR Pharma among ASX health companies reporting clinical milestones reached in quarterly results.
Understanding the importance of defensible medical cannabis pricing data is crucial for investors and operators navigating ...
Discover how smarter, real-time clinical trials could reshape drug development, offering more efficient pathways for new ...
Conference call scheduled for Thursday, April 30, 2026, at 8:30 am ET to review new OST-HER2 immune pharmacodynamic biomarker response (seroconversion) data and review regulatory successes validating ...
This report explores how firms are evolving their use of analytics across the execution lifecycle, from pre-trade ...
Single-cell analysis is reshaping drug discovery, but interpretation remains slow. AI single cell approaches may close the ...
Anticipated Phased Tier IV Development in "Data Center Valley" Planned to Anchor the 2026 Global "Inference Flip" ...
1dOpinion
Tredegar: The Tariff Isn't Helping
Tredegar faces persistent structural challenges and has failed to adapt to tariff-induced industry changes. Read why I rate ...
Fundamental analysis tries to determine value and estimate the future market price based on a stock's underlying fundamentals. Technical analysis relies on charts to forecast prices. The goal of ...
Major League Baseball opened the 2026 season with a technological first: the Automated Ball-Strike or ABS Challenge System, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results